We are live on
!
Find out more
PM
Prosight Management Portfolio holdings
AUM
$610M
1-Year Est. Return
40.86%
This Fund
S&P 500
This Quarter
Est. Return
+7.6%
1 Year Est. Return
+40.86%
3 Year Est. Return
+46.17%
5 Year Est. Return
+1.2%
10 Year Est. Return
–
AUM
$176M
AUM Growth
+$40.2M
(+29%)
Cap. Flow
+$32.6M
Cap. Flow
% of AUM
18.5%
Top 10 Holdings %
Top 10 Hldgs %
61.25%
Holding
42
New
11
Increased
10
Reduced
10
Closed
10
Top Buys
| 1 |
HNGR
Hanger Inc.
HNGR
|
+$26M |
| 2 |
Zimmer Biomet
ZBH
|
+$7.83M |
| 3 |
MODV
ModivCare
MODV
|
+$5.92M |
| 4 |
ALBO
Albireo Pharma Inc
ALBO
|
+$5.33M |
| 5 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
+$4.24M |
Top Sells
| 1 |
Cigna
CI
|
+$8.93M |
| 2 |
AGN
Allergan plc
AGN
|
+$7.4M |
| 3 |
ATHN
Athenahealth, Inc.
ATHN
|
+$6.55M |
| 4 |
CDTX
Cidara Therapeutics
CDTX
|
+$3.68M |
| 5 |
MacroGenics
MGNX
|
+$3.43M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Industrials | 0% |
| 3 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HNGR
1
DELISTED
Hanger Inc.
HNGR
| $25M | 14.17% |
+1,199,602
| New | +$26M |
|
|
TLGT
2
DELISTED
Teligent, Inc
TLGT
| $12.8M | 7.26% |
324,076
-8,424
| -3% | -$338K |
|
|
ARNA
3
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $11.2M | 6.37% |
244,050
+104,522
| +75% | +$4.24M |
|
|
4
MacroGenics
MGNX
$270M
| $9.81M | 5.56% |
457,475
-161,040
| -26% | -$3.43M |
|
5
BioMarin Pharmaceuticals
BMRN
$11.4B
| $9.35M | 5.3% |
96,428
+38,528
| +67% | +$3.85M |
|
|
PVLA
6
Palvella Therapeutics
PVLA
$2.2B
| $9.31M | 5.28% |
20,774
+3,774
| +22% | +$1.64M |
|
|
7
Zimmer Biomet
ZBH
$17.6B
| $8.4M | 4.76% |
+65,848
| New | +$7.83M |
|
8
Iovance Biotherapeutics
IOVA
$1.94B
| $8.05M | 4.56% |
715,317
+275,417
| +63% | +$3.91M |
|
9
Indaptus Therapeutics
INDP
$384M
| $7.55M | 4.28% |
597
+95
| +19% | +$903K |
|
|
RETA
10
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $6.55M | 3.71% |
80,155
-2,939
| -4% | -$207K |
|
|
11
Cigna
CI
$79.6B
| $6.09M | 3.45% |
29,236
-48,164
| -62% | -$8.93M |
|
|
AGN
12
DELISTED
Allergan plc
AGN
| $5.98M | 3.39% |
31,400
-40,300
| -56% | -$7.4M |
|
|
MODV
13
DELISTED
ModivCare
MODV
| $5.73M | 3.25% |
+85,217
| New | +$5.92M |
|
|
ALBO
14
DELISTED
Albireo Pharma Inc
ALBO
| $5.37M | 3.04% |
+162,905
| New | +$5.33M |
|
15
Viking Therapeutics
VKTX
$4.39B
| $4.78M | 2.71% |
+274,410
| New | +$3.27M |
|
|
SRRA
16
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $4.62M | 2.62% |
68,002
+22,838
| +51% | +$2.07M |
|
17
Assembly Biosciences
ASMB
$531M
| $4.44M | 2.52% |
9,965
+4,523
| +83% | +$2.12M |
|
18
Kura Oncology
KURA
$998M
| $4.44M | 2.52% |
253,631
-34,256
| -12% | -$657K |
|
|
SHPG
19
DELISTED
Shire pic
SHPG
| $4.24M | 2.4% |
23,400
-8,600
| -27% | -$1.49M |
|
|
EIGR
20
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $4.1M | 2.32% |
11,382
-3,232
| -22% | -$1.11M |
|
21
Centene
CNC
$33B
| $2.88M | 1.63% |
39,750
+18,000
| +83% | +$1.25M |
|
22
Axogen
AXGN
$2.07B
| $2.83M | 1.6% |
+76,741
| New | +$3.35M |
|
23
Evolus
EOLS
$392M
| $2.58M | 1.46% |
+138,460
| New | +$3M |
|
24
Gyre Therapeutics
GYRE
$732M
| $2.55M | 1.45% |
+31,541
| New | +$2.5M |
|
|
SBBP
25
DELISTED
Strongbridge Biopharma plc.
SBBP
| $2.06M | 1.17% |
+423,846
| New | +$2.17M |
|
Similar funds
PL
BFC
ACM
FFWA
SAM
CBB
AIG
IA